Atopic Dermatitis
Conference Coverage
Steroid phobia drives weaker prescribing, nonadherence for AD
The source of these fears can be information from friends, relatives, media, the Internet, as well as doctors.
Latest News
Probiotic LGG doesn’t lessen eczema, asthma, or rhinitis risk by age 7
Study shows no effect when Lactobacillus rhamnosus GG was given in the first 6 months of life. Experts say benefit may lie in a...
Latest News
Managing overuse of food IgE panels: Multiple approaches needed
Beyond wasteful spending, excessive food IgE testing can lead patients to worry needlessly and to avoid foods they aren’t allergic to.
Latest News
Dupilumab under FDA review for atopic dermatitis in children aged 6 months to 5 years
The proposed indication is as add-on therapy for children with moderate to severe AD not adequately controlled with topical prescription therapies...
Conference Coverage
Expert shares workup pearls for children with severe atopic dermatitis
“There is no lower age limit on the use of topical corticosteroids, and low potency corticosteroids are inadequate to treat severe eczema,” Dr....
Latest News
New AAD guidelines eye comorbidities in adults with atopic dermatitis
The guidelines are the first in a four-part series on AD expected to be published over the next 1-2 years.
Latest News
Perception of atopic dermatitis severity often differs between patients, physicians
“The use of multiple assessment tools that measure different domains could potentially help better capture the broad manifestations of AD.”
News from the FDA/CDC
FDA approves two JAK-1 inhibitors for moderate to severe atopic dermatitis
“It’s big news because a few years ago we didn’t have any systemic treatments that are safer than the classical immunosuppressants.”
Conference Coverage
Sorting out sleep complaints in children with AD can be complex
“There’s a loss of about 50 minutes of sleep per night in children with AD,” Dr. Stephen H. Sheldon said.
Conference Coverage
Longitudinal course of atopic dermatitis often overlooked, expert says
“Understanding the long-term course may improve our ability to phenotype, prognosticate, and personalize our care,” Dr. Raj Chovatiya said.
Conference Coverage
AD burden may be greater for those with head, neck, face, and hand involvement
“These findings highlight the importance of detailed assessment of specific areas affected by AD to personalize treatment approaches to the needs...